Clinical considerations in early-onset cerebral amyloid angiopathy
It is estimated that only about 66% of people who are prescribed CPAP are properly adherent, which has remained largely unchanged over the past two decades
This is a common concern for patients considering or taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or liraglutide (Saxenda, Victoza) for type 2 diabetes or weight management
However, the efficacy of GLP-1R agonists to reduce drinking in this subgroup may diverge from those without surgery, as GLP-1 is increased after surgery ( In conclusion, these preclinical and clinical studies point toward the possibility of using GLP-1R agonists to treat patients with addictions, an interaction that should be elucidated in future studies
Recommendation 2 In adults living with obesity who are prescribed GLP-1 therapies, intensive behavioral therapy may be provided as part of a comprehensive multimodal clinical algorithm